COA 2024: Intra-Articular vs. Intravenous Tranexamic Acid in Primary Unilateral TKA
COA 2024: Intra-Articular vs. Intravenous Tranexamic Acid in Primary Unilateral TKA
Comparison Between Intra-Articular and Intravenous Tranexamic Acid Application in Primary Unilateral Knee Joint Replacement
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
CONFERENCE ACE REPORTS
This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.
Synopsis
Seventy-eight patients with osteoarthritis undergoing primary total knee arthroplasty were randomized to receive either intravenous tranexamic acid or intra-articular tranexamic acid. Outcomes included post-operative blood loss, measured by drain output, hemoglobin level drop, and the need for blood transfusion. Outcomes were assessed immediately after surgery and at 12 and 24 hours post-operative...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.